Evaluation of the Relationship Between Clinical Features of Acrochordons and Metabolic Syndrome Components: Prospective Cross-Sectional Study

Objective: The aim of this study is to assess the metabolic syndrome components in patients with acrochordons. Material and Methods: A total of 53 patients were included to this prospective crosssectional designed study. Demographics, characteristics of acrochordons, body mass index (BMI), waist circumference, blood pressure, fasting blood glucose and lipid parameters were recorded. Results: The mean acrochordon count was 28.77±23.009 (minimum: 3, maximum: 105). 62.3% (n=33) of the patients had pigmented acrochordons. The most common localization of acrochordons was neck (n=52, 98.8%). The mean BMI was 32.54±5.073. 67.9% (n=36) of the patients were obese and 28.3% (n=15) of the patients were overweight. 33.9% (n=18) of the patients had hypertension, %49 (n=26) of the patients had impaired fasting glucose or diabetes mellitus, 73.6% (n=39) of the patients had dyslipidemia and 58.5% (n=31) of the patients were diagnosed as metabolic syndrome. There was a low correlation between total acrochordon count and BMI (p=0.043; r=0.279) and a moderate correlation with systolic blood pressure (p=0.04, r=0.385). When we categorized the total acrochordon count as ≤10 and >10; there was a statistically significant difference between the presence of hypertension and pre-diabetes/diabetes (p=0.04 and 0.04, respectively). The presence of hypertension and metabolic syndrome was found to be significantly higher in those with pigmented acrochordon than in those without it (p=0.001 and 0.01, respectively). Conclusion: Further evaluation may be necessary for those with >10 acrochordons, especially in terms of hypertension and pre-diabetes/diabetes, and for hypertension and metabolic syndrome in those with pigmented acrochordons.